Picture of Lucy Scientific Discovery logo

LSDIF Lucy Scientific Discovery Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Lucy Scientific Discovery, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M
Source:PROSPECTUS/APROSPECTUS/APROSPECTUS/A10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-3-4.73-5.86-8.99
Non-Cash Items2.023.482.64.58
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.484-0.2370.8410.143
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities-0.499-1.48-2.42-4.27
Capital Expenditures0-0.034-0.3
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.034
Sale of Fixed Assets
Cash from Investing Activities0-0.034-0.266
Financing Cash Flow Items0.3810.707-0.667-1.44
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.5351.72.256.19
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0380.196-0.1931.62